Loading…
The impact of gender on clinical manifestations of primary antiphospholipid syndrome
The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphos...
Saved in:
Published in: | Lupus 2005-08, Vol.14 (8), p.607-612 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33 |
---|---|
cites | cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33 |
container_end_page | 612 |
container_issue | 8 |
container_start_page | 607 |
container_title | Lupus |
container_volume | 14 |
creator | Jara, L J Medina, G Vera-Lastra, O Barile, L |
description | The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings. |
doi_str_mv | 10.1191/0961203305lu2176oa |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68610129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1191_0961203305lu2176oa</sage_id><sourcerecordid>896410041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</originalsourceid><addsrcrecordid>eNp9kD9PwzAQxS0EoqXwBRhQxMAW6rMTuxkR4p9UiaXMkZOcW1eJHexk6LcnUSNVAonhdMP97t27R8gt0EeADJY0E8Ao5zStewZSOHVG5pBIGQ8Tdk7mIxCPxIxchbCnlHLIxCWZgQCZZpzNyWazw8g0rSq7yOloi7ZCHzkblbWxplR11ChrNIZOdcbZMEKtN43yh0jZzrQ7F4aqTWuqKBxs5V2D1-RCqzrgzdQX5Ov1ZfP8Hq8_3z6en9ZxmfCkixUHhBRRFymgpkrKgmIlM5lonjJdUC4S1ForxpFXAjkrypWUqyoFLQE5X5CHo27r3Xc_eMwbE0qsa2XR9SEXKwEUWDaA97_Aveu9HbzljDEBfMWSAWJHqPQuBI86nx7NgeZj4PnfwIelu0m5LxqsTitTwgOwPAJBbfF09h_JH9PAi7U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222613824</pqid></control><display><type>article</type><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><source>Sage Journals Online</source><creator>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</creator><creatorcontrib>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</creatorcontrib><description>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1191/0961203305lu2176oa</identifier><identifier>PMID: 16175932</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adult ; Antibodies, Anticardiolipin - blood ; Anticoagulants ; Antiphospholipid Syndrome - blood ; Antiphospholipid Syndrome - complications ; Cardiovascular Diseases - etiology ; Disease ; Epidemiology ; Female ; Females ; Follow-Up Studies ; Gender ; Hospitals ; Humans ; Kidney Diseases - etiology ; Lupus ; Male ; Males ; Middle Aged ; Retrospective Studies ; Sex Factors ; Skin Diseases - etiology ; Thrombocytopenia ; Thrombocytopenia - etiology ; Thrombosis ; Womens health</subject><ispartof>Lupus, 2005-08, Vol.14 (8), p.607-612</ispartof><rights>2005 Arnold</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</citedby><cites>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16175932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jara, L J</creatorcontrib><creatorcontrib>Medina, G</creatorcontrib><creatorcontrib>Vera-Lastra, O</creatorcontrib><creatorcontrib>Barile, L</creatorcontrib><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><title>Lupus</title><addtitle>Lupus</addtitle><description>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</description><subject>Adult</subject><subject>Antibodies, Anticardiolipin - blood</subject><subject>Anticoagulants</subject><subject>Antiphospholipid Syndrome - blood</subject><subject>Antiphospholipid Syndrome - complications</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Disease</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Females</subject><subject>Follow-Up Studies</subject><subject>Gender</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Kidney Diseases - etiology</subject><subject>Lupus</subject><subject>Male</subject><subject>Males</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sex Factors</subject><subject>Skin Diseases - etiology</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - etiology</subject><subject>Thrombosis</subject><subject>Womens health</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kD9PwzAQxS0EoqXwBRhQxMAW6rMTuxkR4p9UiaXMkZOcW1eJHexk6LcnUSNVAonhdMP97t27R8gt0EeADJY0E8Ao5zStewZSOHVG5pBIGQ8Tdk7mIxCPxIxchbCnlHLIxCWZgQCZZpzNyWazw8g0rSq7yOloi7ZCHzkblbWxplR11ChrNIZOdcbZMEKtN43yh0jZzrQ7F4aqTWuqKBxs5V2D1-RCqzrgzdQX5Ov1ZfP8Hq8_3z6en9ZxmfCkixUHhBRRFymgpkrKgmIlM5lonjJdUC4S1ForxpFXAjkrypWUqyoFLQE5X5CHo27r3Xc_eMwbE0qsa2XR9SEXKwEUWDaA97_Aveu9HbzljDEBfMWSAWJHqPQuBI86nx7NgeZj4PnfwIelu0m5LxqsTitTwgOwPAJBbfF09h_JH9PAi7U</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Jara, L J</creator><creator>Medina, G</creator><creator>Vera-Lastra, O</creator><creator>Barile, L</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200508</creationdate><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><author>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Antibodies, Anticardiolipin - blood</topic><topic>Anticoagulants</topic><topic>Antiphospholipid Syndrome - blood</topic><topic>Antiphospholipid Syndrome - complications</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Disease</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Females</topic><topic>Follow-Up Studies</topic><topic>Gender</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Kidney Diseases - etiology</topic><topic>Lupus</topic><topic>Male</topic><topic>Males</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sex Factors</topic><topic>Skin Diseases - etiology</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - etiology</topic><topic>Thrombosis</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jara, L J</creatorcontrib><creatorcontrib>Medina, G</creatorcontrib><creatorcontrib>Vera-Lastra, O</creatorcontrib><creatorcontrib>Barile, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jara, L J</au><au>Medina, G</au><au>Vera-Lastra, O</au><au>Barile, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2005-08</date><risdate>2005</risdate><volume>14</volume><issue>8</issue><spage>607</spage><epage>612</epage><pages>607-612</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>16175932</pmid><doi>10.1191/0961203305lu2176oa</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0961-2033 |
ispartof | Lupus, 2005-08, Vol.14 (8), p.607-612 |
issn | 0961-2033 1477-0962 |
language | eng |
recordid | cdi_proquest_miscellaneous_68610129 |
source | Sage Journals Online |
subjects | Adult Antibodies, Anticardiolipin - blood Anticoagulants Antiphospholipid Syndrome - blood Antiphospholipid Syndrome - complications Cardiovascular Diseases - etiology Disease Epidemiology Female Females Follow-Up Studies Gender Hospitals Humans Kidney Diseases - etiology Lupus Male Males Middle Aged Retrospective Studies Sex Factors Skin Diseases - etiology Thrombocytopenia Thrombocytopenia - etiology Thrombosis Womens health |
title | The impact of gender on clinical manifestations of primary antiphospholipid syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A47%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20gender%20on%20clinical%20manifestations%20of%20primary%20antiphospholipid%20syndrome&rft.jtitle=Lupus&rft.au=Jara,%20L%20J&rft.date=2005-08&rft.volume=14&rft.issue=8&rft.spage=607&rft.epage=612&rft.pages=607-612&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1191/0961203305lu2176oa&rft_dat=%3Cproquest_cross%3E896410041%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222613824&rft_id=info:pmid/16175932&rft_sage_id=10.1191_0961203305lu2176oa&rfr_iscdi=true |